| Literature DB >> 28241482 |
Izabela Michalak1, Agnieszka Dmytryk2, Agnieszka Śmieszek3, Krzysztof Marycz4.
Abstract
The green seaweed Enteromorpha prolifera was used as a feedstock for the production of enzymatic hydrolysate using cellulase. The selection of the conditions for enzymatic hydrolysis of the biomass was carried out for different enzyme doses and incubation periods. The obtained extract was examined in terms of its multielemental composition, content of polyphenols and antibacterial properties (tested against Escherichia coli and Staphylococcus aureus). Additionally, its influence on the metabolic activity of human colon epithelial cells (Caco-2) was analyzed. The tested concentrations of extract using an in vitro model were 62.5, 125, 250, 500, 1000 and 2000 µg/mL. The hydrolysis yield in the most suitable experimental conditions (8-h process and 50 and 100 µL of cellulase) was 36%. Micro- and macroelements were poorly extracted from the algal biomass. Total phenolic content was 55 mg of gallic acid equivalent per 100 g of dry mass of extract. The cytotoxic effect of extracts, related to the inhibition of the metabolic activity of Caco-2, was noted only after 24 h. In turn, cultures of Caco-2 propagated with extracts for 72 h were characterized by significantly elevated metabolism (the concentration of extracts ranged from 62.5 to 1000 µg/mL, p < 0.05). Obtained results indicated the high biological activity of the prepared extracts; however, the observed effects did not occur in a dose-dependent manner.Entities:
Keywords: algae; cellulase; cytotoxicity; elemental composition; enzymatic extract; polyphenols
Mesh:
Substances:
Year: 2017 PMID: 28241482 PMCID: PMC5372495 DOI: 10.3390/ijms18030479
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The number of scientific papers on extraction techniques of algae [2].
Examples of the enzyme-assisted extraction of biologically active compounds from the biomass of macroalgae and their applications.
| Enzyme | Alga | Extracted Compound | Method | Application | Reference |
|---|---|---|---|---|---|
| Neutrase 0.8 L (endoprotease—neutral | crude polysaccharide (fucose, galactose, and glucose) | 50 g A, 5 g E, 0.2 M PB, pH 8, 50 °C, 12 h | inhibitory activities against cancer cell growth, induction of apoptosis in HL-60 tumor cells | [ | |
| Alginate lyase (combined extraction method: enzyme pre-treated | fucoxanthin, lipids containing polyunsaturated fatty acid | 0.05% ( | possible alternative to ethanol for the extraction of fucoxanthin from | [ | |
| Carbohydrases (cellulase, xylanase, arabanase, β-glucanase); Proteases (endopeptidase, endoprotease) | soluble protein, polyphenol, neutral sugars, uronic acids, sulphated polysaccharides | 500 g A, 0.5% ( | antiviral activity without cytotoxicity effect–tested Herpes simplex virus 1 (HSV-1) | [ | |
| Carbohydrase (cellulase, β-glucanase, Ultaflo (heat-stable multi-active β-glucanase)); Protease | protein, neutral sugars, uronic acids, and sulfates | 1 and 10 g A, 0.5% E, 200 mL H2O, 50 °C, 3 h | functional food and antiviral drug discovery—the enzymatic hydrolysates exhibited significant activity against HSV-1 | [ | |
| Carbohydrases: Celluclast (β-glucanase), exo-1,4-α- | 1 g A, 100 µL (or mg) E, 100 mL of buffer (AB for Viscozyme, AMG, Celluclast, for the rest—PB), 12 h | antioxidant activity (use in different food formulations and pharmaceutical industry) | [ | ||
| Carbohydrases: Celluclast (β-glucanase), exo-1,4-α- | antioxidant compounds | 1 g A, 100 µL (or mg) E, 100 mL of buffer (AB for Viscozyme, AMG, Celluclast, for the rest—PB), 12 h | antioxidant activity (use in different food formulations and pharmaceutical industry) | [ | |
| Viscozyme L (cellulase) | - | 1 g A, 1%, 2% and 5% ( | production of bioethanol | [ | |
| Carbohydrases (amyloglucosidase 300 L (AMG), Celluclast 1.5 L FG, Dextrozyme, Maltogenase, Promozyme, Viscozyme L and Termamyl); Proteases (Alcalase 2.4 L FG, Flavourzyme 500 MG, Neutrase 0.8 L, Protamex) | - | 1 g A, 20 mg E, 60 mL of H2O, 8 h | antioxidant, anti-acetylcholinesterase and anti-inflammatory activity | [ | |
| Carbohydrases (Viscozyme, Celluclast, Termamyl and Ultraflo); Proteases (Protamex, Kojizyme, Neutrase, Flavourzyme and Alcalase) | antioxidant compounds—polyphenols | 1 g A, 100 mL of distilled water, 5%—enzyme/substrate ratio, 3 days, final pH 7.0 | antioxidant activity | [ |
A: Dried alga; E: Enzyme; PB: Phosphate buffer; AB: Acetate buffer; B: Brown macroalga; G: Green macroalga; R: Red macroalga.
The multielemental composition of raw algal biomass, algal extract obtained by the enzyme-assisted extraction and post-extraction residue (n = 3).
| Element | Wavelength (nm) | Algae before Extraction (mg/kg of Dry Mass (d.m.)) | Algal Extract—EAE (mg/L) | Post-Extraction Residue of Algae (mg/kg of d.m.) | Algal Extract—SFE * (mg/L) [ | Algal Extract—MAE ** (mg/L) [ |
|---|---|---|---|---|---|---|
| As | 188.980 | <LLD | <LLD | <LLD | 0.72 ± 0.09 (EP: 7.4%) | 0.198 ± 0.025 (EP: 5.1%) |
| B | 249.772 | 231 ± 35 | 4.69 ± 0.70 (EP: 2.0%) | 37.2 ± 5.6 | <LLD | 4.74 ± 0.71 (EP: 4.8%) |
| Ba | 455.403 | 26.9 ± 4.0 | 1.04 ± 0.16 (EP: 3.9%) | 26.4 ± 4.0 | - | - |
| Ca | 315.887 | 16,540 ± 3308 | 381 ± 57 (EP: 7.4%) | 9412 ± 1882 | 1060 ± 210 (EP: 7.4%) | 365 ± 54 (EP: 0.9%) |
| Cd | 228.802 | 0.260 ± 0.039 | <LLD | 0.010 ± 0.002 | <LLD | 0.001 ± 0.000 (EP: 0.14%) |
| Co | 228.615 | 2.41 ± 0.36 | 0.035 ± 0.009 (EP: 1.6%) | 1.49 ± 0.22 | 0.026 ± 0.004 (EP: 0.54%) | 0.0135 ± 0.0034 (EP: 0.47%) |
| Cr | 267.716 | 3.79 ± 0.57 | 0.022 ± 0.006 (EP: 0.58%) | 3.65 ± 0.55 | 0.31 ± 0.05 (EP: 2.4%) | - |
| Cu | 324.754 | 7.09 ± 1.06 | 0.23 ± 0.03 (EP: 3.2%) | 6.50 ± 0.97 | 6.3 ± 0.9 (EP: 22%) | 0.108 ± 0.016 (EP: 0.85%) |
| Fe | 259.940 | 2440 ± 488 | 17.3 ± 2.6 (EP: 0.71%) | 2114 ± 423 | 9.2 ± 1.4 (EP: 0.1%) | 4.47 ± 0.70 (EP: 0.07%) |
| K | 766.491 | 2705 ± 541 | 42.3 ± 6.3 (EP: 1.6%) | 1293 ± 259 | 52 ± 8 (EP: 1.1%) | 951 ± 142 (EP: 19%) |
| Mg | 285.213 | 5993 ± 1199 | 142 ± 21 (EP: 2.4%) | 5180 ± 1036 | 406 ± 61 (EP: 10%) | 322 ± 48 (EP: 10%) |
| Mn | 257.61 | 322 ± 48 | 7.09 ± 1.06 (EP: 2.2%) | 281 ± 42 | 6.6 ± 1.0 (EP: 2.4%) | 3.07 ± 0.46 (EP: 1.3%) |
| Na | 588.995 | 2586 ± 517 | 1593 ± 319 (EP: 62%) | 1887 ± 377 | 965 ± 145 (EP: 17%) | 1250 ± 250 (EP: 20%) |
| Ni | 231.604 | 9.01 ± 1.35 | 0.255 ± 0.038 (EP: 2.8%) | 6.29 ± 0.94 | 0.27 ± 0.04 (EP: 3.0%) | 0.132 ± 0.019 (EP: 2.5%) |
| P | 213.618 | 1168 ± 234 | 15.1 ± 2.3 (EP: 1.3%) | 923 ± 138 | 43 ± 6 (EP: 2.8%) | 32.9 ± 4.9 (EP: 2.8%) |
| S | 181.972 | 18,381 ± 3676 | 292 ± 44 (EP: 1.6%) | 10,890 ± 2178 | 9300 ± 1900 (EP: 92%) | 702 ± 105 (EP: 8.1%) |
| Si | 251.611 | 668 ± 100 | 6.65 ± 0.99 (EP: 1.0%) | 682 ± 102 | - | 11.9 ± 1.8 (EP: 1.3%) |
| Zn | 213.857 | 227 ± 34 | 3.70 ± 0.56 (EP: 1.6%) | 64.3 ± 9.6 | 5.2 ± 0.8 (EP: 3.0%) | 0.169 ± 0.025 (EP: 0.26%) |
* SFE: Supercritical fluid extraction of Baltic macroalgae; ** MAE: Microwave-assisted extraction of Baltic macroalgae (60 °C); EP: Extraction percentage from raw algal biomass;
Concentration of released reducing sugars (RRS) as glucose equivalent in enzymatic extracts from Enteromorpha prolifera at a given control point.
| Enzyme Dose (μL) Time (h) | 10 | SSDD | 20 | SSDD | 50 | SSDD | 100 | SSDD | |
|---|---|---|---|---|---|---|---|---|---|
| (Control Point) | |||||||||
| 6 (1st) | Mean glucose concentration ± standard deviation (mg/mL) | ||||||||
| SSDT | 0.998 a,b,A,c,d,e,f ± 0.005 | A | 0.969 g,h,i,j,k,B,l,m,n,o ± 0.005 | b | 1.02 p,q,r ± 0.01 | e,f,g | 1.03 s,C,t ± 0.01 | i,j,B | |
| 8 (2nd) | - | - | - | - | |||||
| SSDT | 1.09 g,u,w,D ± 0.01 | A,a | 1.08 x,y ± 0.01 | b,c,d | 1.20 a,h,s,z,α,β,γ,δ,ε,ζ ± 0.01 | e,h | 1.20 b,i,p,η,θ,ι,κ,λ,μ,ξ ± 0.02 | i,k | |
| 10 (3rd) | a,b | c,d | a,c | b,d | |||||
| SSDT | 1.03 z,η,E,F,π,ρ ± 0.03 | 0.976 u,α,θ,ς,σ,τ,υ ± 0.008 | c | 1.09 A,j,ι,φ,χ,ψ ± 0.04 | h | 1.08 k,β,ω,G ± 0.05 | k,m | ||
| 12 (4th) | e,f | e | f | ||||||
| SSDT | 1.06 B,γ,κ,H,ä ± 0.02 | 1.03 δ,λ,ë,ï ± 0.02 | 1.12 c,l,C,E,ς,ö,ø ± 0.00 | f | 1.12 d,m,q,F,σ,ü,ÿ ± 0.02 | j | |||
| 24 (5th) | A,B | A | B | ||||||
| SSDT | 0,976 x,ε,μ,φ,ω,ö,ü ± 0.024 | a | 0,980 w,ζ,ξ,χ,G,ø,ÿ ± 0.024 | d | 1.15 e,n,t,π,τ,H,ë ± 0.05 | g | 1.19 f,o,r,D,y,ρ,υ,ψ,ä,ï ± 0.07 | B,m | |
| 6 (1st) | g,h | i,j | g,i | h,j | |||||
SSDD: Statistically significant differences indicated between the results for the same enzyme dose at consecutive control points (extraction time); SSDT: Statistically significant differences indicated between the results for different enzyme doses at the same control point (extraction time); a, b…z; α, β…ω; ä, ë…ÿ: Pairwise indication of statistically significant differences at p < 0.01; A, B…H: Pairwise indication of statistically significant differences at p < 0.05.
Total activity of Celluclast 1.5 at a given control point.
| Enzyme Dose (μL) Time (h) | 10 | SSDD | 20 | SSDD | 50 | SSDD | 100 | SSDD | |
|---|---|---|---|---|---|---|---|---|---|
| (Control Point) | |||||||||
| Total enzyme activity (U) | |||||||||
| 6 (1st) | 1.54 ± 0.01 | a,b,c,d | 1.49 ± 0.01 | k,l,m,n | 1.58 ± 0.01 | u,v,w,x | 1.59 ± 0.01 | ε,ζ,η,θ | |
| SSDT | a,b | a | b | ||||||
| 8 (2nd) | 1.26 ± 0.01 | a,e,f,g | 1.24 ± 0.01 | k,o,p,q | 1.38 ± 0.02 | u,y,z,α | 1.38 ± 0.02 | ε,ι,κ,λ | |
| SSDT | c,d | e,f | c,e | d,f | |||||
| 10 (3rd) | 0.939 ± 0.031 | b,e,h,i | 0.894 *,** ± 0.007 | l,o,r,s | 0.999 ± 0.040 | v,y,β,γ | 0.987 ± 0.042 | ζ,ι,μ,ξ | |
| SSDT | A | g,h | A,g | h | |||||
| 12 (4th) | 0.796 ± 0.015 | c,f,h,j | 0.777 ± 0.013 | m,p,r,t | 0.844 * ± 0.003 | w,z,β,δ | 0.844 ** ± 0.012 | η,κ,μ,π | |
| SSDT | B,i | B | i | ||||||
| 24 (5th) | 0.365 ± 0.009 | d,g,i,j | 0.366 ± 0.009 | n,q,s,t | 0.429 ± 0.018 | x,α,γ,δ | 0.446 ± 0.024 | θ,λ,ξ,π | |
| SSDT | C,j | D,k | C,D | j,k | |||||
| Absolute enzyme activity (U/mL) | |||||||||
| 6 (1st) | 154 A,B ± 1 | 74.7 ± 0.4 | 31.5 ± 0.2 | 15.9 ± 0.1 | |||||
| 8 (2nd) | 127 C ± 1 | 62.4 ± 0.5 | 27.8 ± 0.3 | 13.9 ± 0.2 | |||||
| 10 (3rd) | 94.8 ± 3.1 | 45.1 ± 0.4 | 20.2 ± 0.8 | 10.0 ± 0.4 | |||||
| 12 (4th) | 81.6 ± 1.5 | 39.8 ± 0.7 | 17.3 ± 0.1 | 8.66 A ± 0.12 | |||||
| 24 (5th) | 37.6 ± 0.9 | 18.9 ± 0.5 | 8.85 ± 0.38 | 4.60 B,C ± 0.25 | |||||
SSDD: Statistically significant differences indicated between the results for the same enzyme dose at consecutive control points (extraction time); SSDT: Statistically significant differences indicated between the results for different enzyme doses at the same control point (extraction time); a–z, α–π: Pairwise indication of statistically significant differences at p < 0.01; A–D: Pairwise indication of statistically significant differences at p < 0.05; *,**: Pairwise indication of non-significantly different results (p ≥ 0.05).
Figure 2The influence of the E. prolifera extracts on Caco-2 metabolic activity. The statistically significant differences were tested at p level 0.05 (statistically significant difference marked as “a”). The normative value was determined based on a control culture’s metabolic activity (red line).
Methodology of E. prolifera hydrolysis based on literature data.
| 1 × 10−2 | * | |
| 2 × 10−2 | * | |
| 5 × 10−2 | * | |
| 9.99 × 10−2 | [ | |
| 1 g:100 mL (each enzyme dose) | [ | |
| 4 g:200 mL (selected enzyme dose) | [ | |
| Citrate buffer, pH 4.8 | [ | |
| 50 °C | [ | |
| Rotary shaking, 200 rpm | * | |
| 6 h | * | |
| 8 h | [ | |
| 10 h | * | |
| 12 h | [ | |
| 24 h | * |
*: Variables developed for the present work.